Cargando…
2LARTH(®), a micro-immunotherapy medicine, exerts anti-inflammatory effects in vitro and reduces TNF-α and IL-1β secretion
BACKGROUND: Tumor necrosis factor-α (TNF-α) and IL-1β are 2 pro-inflammatory cytokines known to be involved in rheumatic diseases. The therapeutic strategy used in micro-immunotherapy (MI) to reduce chronic inflammation and attenuate pain consists in mainly targeting these 2 cytokines. 2LARTH(®) is...
Autores principales: | Floris, Ilaria, Appel, Kurt, Rose, Thorsten, Lejeune, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211308/ https://www.ncbi.nlm.nih.gov/pubmed/30464572 http://dx.doi.org/10.2147/JIR.S174326 |
Ejemplares similares
-
The Micro-Immunotherapy Medicine 2LARTH® Reduces Inflammation and Symptoms of Rheumatoid Arthritis In Vivo
por: Floris, Ilaria, et al.
Publicado: (2020) -
Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH(®) Micro-Immunotherapy Treatment
por: Jacques, Camille, et al.
Publicado: (2021) -
Pro-Inflammatory Cytokines at Ultra-Low Dose Exert Anti-Inflammatory
Effect In Vitro: A Possible Mode of Action Involving Sub-Micron
Particles?
por: Floris, Ilaria, et al.
Publicado: (2020) -
Potential Role of the Micro-Immunotherapy Medicine 2LALERG in the
Treatment of Pollen-Induced Allergic Inflammation
por: Floris, Ilaria, et al.
Publicado: (2020) -
A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model
por: Jacques, Camille, et al.
Publicado: (2022)